These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 23970796)

  • 1. De novo generation of infectious prions with bacterially expressed recombinant prion protein.
    Zhang Z; Zhang Y; Wang F; Wang X; Xu Y; Yang H; Yu G; Yuan C; Ma J
    FASEB J; 2013 Dec; 27(12):4768-75. PubMed ID: 23970796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant prion protein refolded with lipid and RNA has the biochemical hallmarks of a prion but lacks in vivo infectivity.
    Timmes AG; Moore RA; Fischer ER; Priola SA
    PLoS One; 2013; 8(7):e71081. PubMed ID: 23936256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preserving prion strain identity upon replication of prions in vitro using recombinant prion protein.
    Makarava N; Savtchenko R; Lasch P; Beekes M; Baskakov IV
    Acta Neuropathol Commun; 2018 Sep; 6(1):92. PubMed ID: 30208966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Self-propagating, protease-resistant, recombinant prion protein conformers with or without in vivo pathogenicity.
    Wang F; Wang X; Orrú CD; Groveman BR; Surewicz K; Abskharon R; Imamura M; Yokoyama T; Kim YS; Vander Stel KJ; Sinniah K; Priola SA; Surewicz WK; Caughey B; Ma J
    PLoS Pathog; 2017 Jul; 13(7):e1006491. PubMed ID: 28704563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prion infectivity is encoded exclusively within the structure of proteinase K-resistant fragments of synthetically generated recombinant PrP
    Wang F; Wang X; Abskharon R; Ma J
    Acta Neuropathol Commun; 2018 Apr; 6(1):30. PubMed ID: 29699569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conversion of bacterially expressed recombinant prion protein.
    Wang F; Wang X; Ma J
    Methods; 2011 Mar; 53(3):208-13. PubMed ID: 21176786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of 2 synthetically generated recombinant prions.
    Zhang Y; Wang F; Wang X; Zhang Z; Xu Y; Yu G; Yuan C; Ma J
    Prion; 2014; 8(2):215-20. PubMed ID: 24721728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generating a prion with bacterially expressed recombinant prion protein.
    Wang F; Wang X; Yuan CG; Ma J
    Science; 2010 Feb; 327(5969):1132-5. PubMed ID: 20110469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolation of novel synthetic prion strains by amplification in transgenic mice coexpressing wild-type and anchorless prion proteins.
    Raymond GJ; Race B; Hollister JR; Offerdahl DK; Moore RA; Kodali R; Raymond LD; Hughson AG; Rosenke R; Long D; Dorward DW; Baron GS
    J Virol; 2012 Nov; 86(21):11763-78. PubMed ID: 22915801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of genuine prion infectivity by serial PMCA.
    Weber P; Giese A; Piening N; Mitteregger G; Thomzig A; Beekes M; Kretzschmar HA
    Vet Microbiol; 2007 Aug; 123(4):346-57. PubMed ID: 17493773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of the highly conserved middle region of prion protein (PrP) in PrP-lipid interaction.
    Wang F; Yin S; Wang X; Zha L; Sy MS; Ma J
    Biochemistry; 2010 Sep; 49(37):8169-76. PubMed ID: 20718504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seeding specificity and ultrastructural characteristics of infectious recombinant prions.
    Piro JR; Wang F; Walsh DJ; Rees JR; Ma J; Supattapone S
    Biochemistry; 2011 Aug; 50(33):7111-6. PubMed ID: 21776987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conformational properties of prion strains can be transmitted to recombinant prion protein fibrils in real-time quaking-induced conversion.
    Sano K; Atarashi R; Ishibashi D; Nakagaki T; Satoh K; Nishida N
    J Virol; 2014 Oct; 88(20):11791-801. PubMed ID: 25078700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contrasting Effects of Two Lipid Cofactors of Prion Replication on the Conformation of the Prion Protein.
    Srivastava S; Baskakov IV
    PLoS One; 2015; 10(6):e0130283. PubMed ID: 26090881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dissociation of infectivity from seeding ability in prions with alternate docking mechanism.
    Miller MB; Geoghegan JC; Supattapone S
    PLoS Pathog; 2011 Jul; 7(7):e1002128. PubMed ID: 21779169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. De novo generation of infectious prions in vitro produces a new disease phenotype.
    Barria MA; Mukherjee A; Gonzalez-Romero D; Morales R; Soto C
    PLoS Pathog; 2009 May; 5(5):e1000421. PubMed ID: 19436715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of the central lysine cluster and scrapie templating in the transmissibility of synthetic prion protein aggregates.
    Groveman BR; Raymond GJ; Campbell KJ; Race B; Raymond LD; Hughson AG; Orrú CD; Kraus A; Phillips K; Caughey B
    PLoS Pathog; 2017 Sep; 13(9):e1006623. PubMed ID: 28910420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cavitation during the protein misfolding cyclic amplification (PMCA) method--The trigger for de novo prion generation?
    Haigh CL; Drew SC
    Biochem Biophys Res Commun; 2015 Jun; 461(3):494-500. PubMed ID: 25892519
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Meyerett-Reid C; Wyckoff AC; Spraker T; Pulford B; Bender H; Zabel MD
    mSphere; 2017; 2(1):. PubMed ID: 28144628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liquid-liquid phase separation of full-length prion protein initiates conformational conversion in vitro.
    Tange H; Ishibashi D; Nakagaki T; Taguchi Y; Kamatari YO; Ozawa H; Nishida N
    J Biol Chem; 2021; 296():100367. PubMed ID: 33545172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.